Shopping Cart 0
Cart Subtotal
AED 0

Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Noven Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Noven Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Noven Pharmaceuticals, Inc. (Noven or 'the company'), a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., is a specialty pharmaceutical company involved in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. These are marketed under Combipatch, Minivelle and Daytrana brands. It also advances patient care through transdermal drug delivery. Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances. Noven is headquartered in Miami, Florida, the US.

Scope

- Detailed information on Noven Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Noven Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Noven Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Noven Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Noven Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Noven Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Noven Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Noven Pharmaceuticals, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Noven Pharmaceuticals, Inc.: Company Overview 9

Noven Pharmaceuticals, Inc.: Overview and Key Facts 9

Noven Pharmaceuticals, Inc.: Overview 9

Noven Pharmaceuticals, Inc.: Key Facts 9

Noven Pharmaceuticals, Inc.: Key Employees 10

Noven Pharmaceuticals, Inc.: Key Employee Biographies 11

Noven Pharmaceuticals, Inc.: Major Products and Services 13

Noven Pharmaceuticals, Inc.: Company History 14

Noven Pharmaceuticals, Inc.: Management Statement 17

Noven Pharmaceuticals, Inc.: Locations and Subsidiaries 18

Noven Pharmaceuticals, Inc.: Key Competitors 19

Noven Pharmaceuticals, Inc.: Company Analysis 20

Noven Pharmaceuticals, Inc.: Business Description 20

Noven Pharmaceuticals, Inc.: SWOT Analysis 21

Noven Pharmaceuticals, Inc.: SWOT Overview 21

Noven Pharmaceuticals, Inc.: Strengths 21

Noven Pharmaceuticals, Inc.: Weaknesses 22

Noven Pharmaceuticals, Inc.: Opportunities 22

Noven Pharmaceuticals, Inc.: Threats 23

Noven Pharmaceuticals, Inc.: Corporate Financial Deals Activity 24

Noven Pharmaceuticals, Inc.: Financial Deals Overview 24

Noven Pharmaceuticals, Inc.: Targets and Partners 25

Noven Pharmaceuticals, Inc.: Top Deals 2014-2018YTD 26

Noven Pharmaceuticals, Inc.: Partnership 27

Noven Pharmaceuticals, Inc.: Recent Developments 28

Noven Pharmaceuticals, Inc.: News and Events Summary 28

Noven Pharmaceuticals, Inc.: Business Expansion 29

Noven Pharmaceuticals, Inc.: Corporate Governance 30

Noven Pharmaceuticals, Inc.: Regulatory and Legal Events 30

Noven Pharmaceuticals, Inc.: Research & Development 33

Noven Pharmaceuticals, Inc.: Strategy and Operations 33

Appendix 34

Contact Us 34

Methodology 34

About MarketLine 35


List Of Figure

List of Figures

Figure 1: Noven Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 2: Noven Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 3: Noven Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)


List Of Table

List of Tables

Table 1: Noven Pharmaceuticals, Inc.: Key Facts

Table 2: Noven Pharmaceuticals, Inc.: Key Employees

Table 3: Noven Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Noven Pharmaceuticals, Inc.: Key Competitors

Table 5: Noven Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 6: Noven Pharmaceuticals, Inc.: Targets and Partners

Table 7: Noven Pharmaceuticals, Inc.: Top Deals 2014-2018YTD

Table 8: Noven Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Table 9: Noven Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Table 10: Noven Pharmaceuticals, Inc.: News and Events Summary

Table 11: Noven Pharmaceuticals, Inc.: Business Expansion

Table 12: Noven Pharmaceuticals, Inc.: Corporate Governance

Table 13: Noven Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 14: Noven Pharmaceuticals, Inc.: Research & Development

Table 15: Noven Pharmaceuticals, Inc.: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Noven Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Noven Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Noven Pharmaceuticals, Inc. (Noven or 'the company'), a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., is a specialty pharmaceutical company involved in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. These are marketed under Combipatch, Minivelle and Daytrana brands. It also advances patient care through transdermal drug delivery. Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances. Noven is headquartered in Miami, Florida, the US.

Scope

- Detailed information on Noven Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Noven Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Noven Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Noven Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Noven Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Noven Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Noven Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Noven Pharmaceuticals, Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Noven Pharmaceuticals, Inc.: Company Overview 9

Noven Pharmaceuticals, Inc.: Overview and Key Facts 9

Noven Pharmaceuticals, Inc.: Overview 9

Noven Pharmaceuticals, Inc.: Key Facts 9

Noven Pharmaceuticals, Inc.: Key Employees 10

Noven Pharmaceuticals, Inc.: Key Employee Biographies 11

Noven Pharmaceuticals, Inc.: Major Products and Services 13

Noven Pharmaceuticals, Inc.: Company History 14

Noven Pharmaceuticals, Inc.: Management Statement 17

Noven Pharmaceuticals, Inc.: Locations and Subsidiaries 18

Noven Pharmaceuticals, Inc.: Key Competitors 19

Noven Pharmaceuticals, Inc.: Company Analysis 20

Noven Pharmaceuticals, Inc.: Business Description 20

Noven Pharmaceuticals, Inc.: SWOT Analysis 21

Noven Pharmaceuticals, Inc.: SWOT Overview 21

Noven Pharmaceuticals, Inc.: Strengths 21

Noven Pharmaceuticals, Inc.: Weaknesses 22

Noven Pharmaceuticals, Inc.: Opportunities 22

Noven Pharmaceuticals, Inc.: Threats 23

Noven Pharmaceuticals, Inc.: Corporate Financial Deals Activity 24

Noven Pharmaceuticals, Inc.: Financial Deals Overview 24

Noven Pharmaceuticals, Inc.: Targets and Partners 25

Noven Pharmaceuticals, Inc.: Top Deals 2014-2018YTD 26

Noven Pharmaceuticals, Inc.: Partnership 27

Noven Pharmaceuticals, Inc.: Recent Developments 28

Noven Pharmaceuticals, Inc.: News and Events Summary 28

Noven Pharmaceuticals, Inc.: Business Expansion 29

Noven Pharmaceuticals, Inc.: Corporate Governance 30

Noven Pharmaceuticals, Inc.: Regulatory and Legal Events 30

Noven Pharmaceuticals, Inc.: Research & Development 33

Noven Pharmaceuticals, Inc.: Strategy and Operations 33

Appendix 34

Contact Us 34

Methodology 34

About MarketLine 35


List Of Figure

List of Figures

Figure 1: Noven Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 2: Noven Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 3: Noven Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)


List Of Table

List of Tables

Table 1: Noven Pharmaceuticals, Inc.: Key Facts

Table 2: Noven Pharmaceuticals, Inc.: Key Employees

Table 3: Noven Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Noven Pharmaceuticals, Inc.: Key Competitors

Table 5: Noven Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 6: Noven Pharmaceuticals, Inc.: Targets and Partners

Table 7: Noven Pharmaceuticals, Inc.: Top Deals 2014-2018YTD

Table 8: Noven Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Table 9: Noven Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Table 10: Noven Pharmaceuticals, Inc.: News and Events Summary

Table 11: Noven Pharmaceuticals, Inc.: Business Expansion

Table 12: Noven Pharmaceuticals, Inc.: Corporate Governance

Table 13: Noven Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 14: Noven Pharmaceuticals, Inc.: Research & Development

Table 15: Noven Pharmaceuticals, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS